GI/Liver Flashcards

1
Q

Describe the presentation, investigation and management of chronic pancreatitis

A

‘a progressive inflammatory condition of the pancreas marked by replacement of the normal parenchyma with fibrous tissue’

Aetiology - TIGAR-O

Toxic/Metabolic, Idiopathic, Genetic, Autoimmune, RAP/SAP Associated, Obstructive

Presents with epigastric pain, weight loss, malabsorption, diabetes, jaundice

Investigations include elevated serum amylase and lipase, serum Ig4, abnormal faecal elastase, calcification on CT, MRCP, EUS, biopsy and labelled carbon breath test for exocrine insufficiency

Manage with lifestyle modification (smoking and alcohol cessation), analgesia, management of exocrine needs (e.g. pancreatic enzyme supplements) and endocrine needs (e.g. diabetes)

May require surgical intervention, such as duct drainage or distal pancreatectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the clinical and histological appearance of acute cholestasis and its most common causes

A

Histological hallmarks include brown bile pigments and features of acute hepatitis

May present with jaundice, signs of gallstones etc.

Causes include extrahepatic biliary obstruction or drug injury (e.g. by antibiotics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the clinical and histological appearance of Fatty Liver Disease and its common causes

A

Risk factors include obesity, HTN, T2DM and hyperlipidaemia

May present with hepatomegaly, nausea, vomiting, diarrhoea, jaundice, ascites, ankle oedema

Histological features include steatosis, alcoholic hepatitis (infiltration by polymorphonuclear leucocytes and hepatocyte necrosis, with giant mitochondria and Mallory bodies)

Mallory bodies are suggestive of alcoholic damage

Alcoholic cirrhosis may also be seen (classically micronodular)

Most common cause is alcohol, however, fatty liver disease may be independent of alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the clinical and histological appearance of chronic hepatitis and its most common causes

A

Characterised by inflammatory cell infiltrate, lobular change, focal lytic necrosis, apoptosis, focal inflammation and fibrosis

Specific causes have specific appearances (e.g. ground glass appearance in hepatitis B)

Specific clinical features will reflect the underlying disease process

Causes include hepatitis B/C, autoimmune disease, Wilson’s disease and haemochromatosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the features of acute and chronic cholecystitis

A

Arises due to obstruction of gallbladder emptying, usually due to gallstones, resulting in distention, compromised blood supply and inflammation

Presents with severe RUQ pain, tenderness and fever

Chronic cholecystitis may be a sequel to repeated attacks of acute cholecystitis

Inflammation in chronic is secondary to chemical damage

Gallstones are virtually always present in chronic cholecystitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the causes of upper GI bleeding

A

Varices - Oesophageal varices arise due to cirrhosis of the liver, which leads to portal hypertension and shunting of blood to the porto-systemic circulation. This causes distention of the blood vessels in the oesophagus, which may become prone to rupture and severe bleeding

Peptic Ulcers - Commonly associated with h. pylori infection and increased gastric acid secretion

Gastritis/Duodenitis/Oesophagitis

Malignancy

Mallory-Weiss Tear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe common hepatic neoplasms

A

Haemangioma - Benign blood vessel tumour

Hepatic Adenoma - Mainly affects young women and is often associated with hormonal therapy

Hepatocellular Carcinoma - Most common primary liver tumour, usually arising in cirrhosis and associated with elevated serum alpha feto-protein

The most common origin of secondary liver malignancy is the GI tract (50%), followed by breast, ovaries, bronchus and kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the pathophysiology of Inflammatory Bowel Disease

A
  • Ulcerative Colitis
    • ‘relapsing and remitting inflammatory disorder of the colonic mucosa which may affect just the rectum or extend to involve part of the colon’
    • Caused by an inappropriate immune response to colonic flora in genetically susceptible individuals
    • Pathological features include hyperaemia, haemorrhagic colonic mucosa with/without pseudopolyps
    • Continuous inflammation is limited to the mucosa
  • Crohn’s
    • ‘a chronic inflammatory disease characterised by transmural granulomatous inflammation affecting any part of the gut from mouth to anus’
    • Unlike UC, there is unaffected bowel between areas of active disease (skip lesions)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the management of Inflammatory Bowel Disease

A
  • Common Treatments
    • Corticosteroids
      • IV Hydrocortisone/Methylprednisolone or Oral Prednisolone
      • Rapid induction of remission
      • Poor evidence for maintaining remission
    • Thiopurines
      • Azathioprine and Mercaptopurine are unlicensed for IBD therapy
      • Effective maintenance therapy
      • Steroid-sparing agent for those requiring 2+ courses a year or relapse on <15mg prednisolone
      • Prevents T-cell clonal expansion in response to antigenic stimuli
    • Biologics
      • Infliximab
        • Murine Anti-TNF Alpha
        • Severe or fistulating Crohn’s or rescue acute severe UC
      • Adalimumab or Golimumab
  • For UC Alone
    • Aminosalicylates
      • Anti-inflammatory
      • Mesalazine most widely used
      • Can cause renal impairment
  • For Crohn’s Alone
    • Methotrexate
      • Anti-inflammatory immunosuppressant
      • Anti-metabolite
      • Side effects include GI upset, hepatotoxicity, immunosuppression, sepsis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the features of liver cysts

A

Usually developmental or degenerative in origin

Most common is the Von Meyenberg complex (a simple biliary hamartoma)

Usually no treatment required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

State the constituents of gallstones and risk factors for their development

A

Stones may be pure cholesterol or bile pigment, but most are mixed

Bile becomes lithogenic for cholesterol if there is excessive secretion of cholesterol or decreased secretion of bile salts

Excessive secretion of bilirubin can cause its precipitation in concentrated bile

Risk factors include increased BMI, increased age, female sex, multiparity and Caucasian race (5 F’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the presentation, investigation and management of pancreatic cancer

A

3% five year survival rate

Risk factors include smoking, male, alcohol, history of chronic pancreatitis, high BMI, family history

Presents with jaundice, abdominal/back pain, weight loss, acute pancreatitis, double duct sign, recent diagnosis of diabetes

Investigate with CT or MRI

Management may be surgical (Whipple’s resection or duct stenting or gastrojejunostomy) or medical (chemotherapy, pancreatic enzyme replacement therapy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the clinical and histological appearance of acute hepatitis and its most common causes

A

Signs and symptoms may be specific to the underlying disease process

Jaundice, malaise, nausea, vomiting, diarrhoea

Appearances include diffuse hepatocyte injury characterised by swelling, cytoplasmic granularity, vacuolation and necrosis

Causes include viruses (Hepatitis A-E and EBV), drugs, alcohol and Wilson’s Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the presentation, investigation and management of exocrine pancreatic insufficiency

A

May arise due to pancreatitis, CF, pancreatectomy

Main presenting feature is malnutrition

Investigate with direct pancreatic function test or indirect (faecal elastase/fat)

Aim of management is to ensure a normal nutritional stats and avoid steatorrhea, weight loss and maldigestion-related symptoms

Treat with pancreatic enzyme supplementation (enteric coated pancreatin) and a PPI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the presentation, investigation and management of acute pancreatitis

A

Aetiology - I GET SMASHED:

Idiopathic, Gallstones, Ethanol, Trauma, Steroids, Mumps/Malignancy, Autoimmune, Scorpion Sting, Hyperlipidaemia, Hypercalcaemia, ERCP/EUS, Drugs (e.g. Azathioprine)

Presents with acute, severe upper abdominal pain (may radiate to back, partially relieved by sitting/bending forward), jaundice, or signs of severe pancreatitis (multi-organ failure, pleural effusions, ascites)

Investigate with serum amylase (3x ULN), serum lipase (remains elevated for longer than serum amylase), AXR, contrast CT and MRCP

Manage with fluid replacement, analgesia, PO/enteral nutrition and antibiotics if septic for mild cases

Treat underlying cause (e.g. abstinence from alcohol or cholecystectomy)

Symptomatic fluid collections may need draining

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the diagnosis of Inflammatory Bowel Disease

A

FBC, CRP, ESR, U&Es, LFTs

Blood Cultures

Stool Cultures

Faecal Calprotectin

AXR

Colonoscopy and Biopsy

Crohn’s - MRI, Endoscopy

17
Q

State the LFT pattern expected in obstructive jaundice

A

Marked elevation in ALP

Mild elevation in ALT/AST

Raised Bilirubin

18
Q

Describe the clinical presentation, investigation and management of cholelithiasis/acute cholecystitis

A

Jaundice, severe RUQ pain, tenderness and fever

USS, X-Ray (only detects 10%), and Bloods (high bilirubin/CSR/ESR, leucocytosis and obstructive LFTs)

Manage with cholecystectomy if does not resolve spontaneously

19
Q

Describe the management of acute upper GI bleed

A

Resuscitation (fluids, oxygen, check bloods)

IV PPIs (reduces re-bleed risk and mortality if given post-endoscopy)

Endoscopic Therapy (adrenaline injection, heater probe and endoscopic clips)

Restrictive Transfusion if Hb <7-8g/dL

Platelets if active bleeding and platelet count <50x109/L

FFP if INR>1.5

Prothrombin Complex Concentrate if on Warfarin and active bleeding

20
Q

Describe the clinical presentation of Inflammatory Bowel Disease

A

Diarrhoea

Abdominal Pain

Weight Loss

Fever, Malaise, Anorexia, Fatigue

Tenesmus

Crohns - Fistulae, Obstruction

UC - Distended Abdomen, Clubbing, Erythema Nodosum, Pyoderma Gangrenosum

21
Q

Describe drug-induced liver disease

A

Common

Drugs can cause almost any pattern of liver disease

Most drug hepatotoxicity is idiosyncratic (rare but usually a single clinical pattern) thus difficult to investigate, e.g. Augmentin

Occasionally there is predictable liver damage, e.g. Paracetamol or Methotrexate

Non-prescribed drugs are important too, e.g. over the internet, illicit or herbal

22
Q

Describe the investigation of upper GI bleeding

A

Risk assessment with Admission Rockall or Glasgow Blatchford score

High Risk - Emergency Endoscopy

Moderate Risk - Admit and Next Day Endoscopy

Low Risk - Consider Out-Patient Management

23
Q

Describe the presentation, investigation and management of biliary sepsis (ascending cholangitis)

A

‘infection of the biliary tree, usually originating at the junction with the duodenum and ascending to the gall bladder, which usually contains gallstones’

Charcot’s Triad (Fever, Jaundice and RUQ Pain)

Reynolds Pentad (Fever, Jaundice, RUQ Pain, Mental Confusion and Septic Shock)

Investigate with raised amylase, obstructive LFTs, raised bilirubin and positive blood cultures

Manage with broad-spectrum antibiotics and ERCP

24
Q

Describe the presentation, investigation and management of Primary Sclerosing Cholangitis

A

‘chronic progressive cholestatic liver disease, characterised by inflammation and fibrosis of the intrahepatic and/or extrahepatic bile ducts, resulting in diffuse, multi-focal stricture formation’

Presents with RUQ pain, pruritis, fever, jaundice, weight loss and fatigue

Investigate with obstructive LFTs, low albumin, prolonged PT, positive ANCA, abdominal USS, MRCP and ERCP

Manage with pruritis relief, immunosuppression, ERCP with stenting of strictures